Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sipuleucel-T With or Without CT-011 and Cyclophosphamide in Advanced Prostate Cancer
NCT01420965Phase 2Terminated
- Sponsor
- Augusta University
- Start
- Sep 2012
- Primary completion
- Dec 2016
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pidilizumab, cyclophosphamide in prostate cancer (PCa), sponsored by Augusta University. Started Sep 2012; status: terminated.
02
Drugs
pidilizumabcyclophosphamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01420965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01420965.